Publication | Closed Access

Targeted doxorubicin delivery and release within breast cancer environment using PEGylated chitosan nanoparticles labeled with monoclonal antibodies

NanoparticlesNanomedicineEngineeringPolymer-drug ConjugateDoxorubicin DeliveryBreast Cancer EnvironmentNano-drug DeliveryPegylated Chitosan NanoparticlesBiomedical EngineeringTumor TargetingPharmacology